Compact analyzers suited to near-patient testing estimate hematocrit by measuring the conductivity of undiluted blood. We evaluated the accuracy of hematocrit determination of one such analyzer (Instrumentation Laboratory BGE Analyzer) against an automated cell counter (EPC) and packed cell volume (PCV) microhematocrit. When specimens (n = 34) from outpatient and ward patients were analyzed with all three methods, the BGE analyzer correlated well with both EPC and PCV hematocrit determinations (BGE = 1.00 PCV + 0.3%, S =
Compact analyzers suited to near-patient testing estimate hematocrit by measuring the conductivity of undiluted blood. We evaluated the accuracy of hematocrit determination of one such analyzer (Instrumentation Laboratory BGE Analyzer) against an automated cell counter (EPC) and packed cell volume (PCV) microhematocrit. When specimens (n = 34) from outpatient and ward patients were analyzed with all three methods, the BGE analyzer correlated well with both EPC and PCV hematocrit determinations (BGE = 1.00 PCV + 0.3%, S = 1.6%; BGE = 1.04 EPC + 0.4%, S, = 2.0%), suggesting that all three methods are similar in performance for most patients. However, a patient with increased plasma osmolality showed significant decreases in BGE and PCV hematocrits relative to the EPC method. The differences in hematocrit measurements could be reproduced by adding solutes to blood in vitro or by modifying the plasma osmolality of rats in vivo. Samples from patients undergoing cardiac surgery, whose blood had large changes in protein concentration, showed discrepancies between hematocrits by conductivity and other methods; similar effects could be produced by changes in protein concentration or in vitro addition of polyethylene glycol. We conclude that conductivity measurements provide accurate hematocrit results for physiologically normal subjects but not for some intensive-care and surgical patients. glucose, blood gases, and calculated variables. These instruments require only small volumes of whole blood and are frequently used in near-patient testing situations such as intensive care, operating areas, and emergency rooms (1) (2) (3) (4) . Placing instruments in these locations ensures immediate availability of results in critical situations, avoids specimen transport problems, and reduces the burden of "stat" requests on the main hospital laboratory.
The availability of hematocrit measurement on these instruments avoids the need to send a separate specimen to the hematology laboratory.
However, the analytical method used by these instruments differs from those used in conventional manual or automated hematocrit measurements (see below) and has been reported to give relatively poor correlation with hematocrit results obtained from major laboratory analyzers and other conductivitybased instruments (1) (2) (3) (4) 
where p = bulk resistivity, pm = resistivity of the medium, f = form factor, and v = volume fraction (%).
Owing to their nonconductive lipid membrane, blood cells have very high resistivity and therefore provide the majority of the particulate contribution to the resistivity of whole blood. Erythrocytes account for most of the volume fraction, and the contribution of other cell types can be ignored in healthy individuals.
This principle is applied in electronic particle counters (EPC) (e.g., the Coulter Counter; Coulter Diagnostics, Hialeah, FL). Whole blood is diluted (1: 6250) in isotonic saline and forced through a narrow orifice that reduces the flow of cells to single file past a pair of electrodes. Continuous monitoring of the resistance between these electrodes allows detection and measurement of the effective volume of individual cells. Because of the high dilution, the value of Pm is governed entirely by the saline diluent, with no significant contribution from plasma components such as nonionized molecules, electrolytes, and proteins. The direct calculation of hematocrit from measurements of the resistivity of undiluted whole blood (basis of analysis in the BGE and similar instruments)
is also based on the simplified form of the Maxwell-Fricke equation (7, 8) . In contrast to EPC, these whole-blood analyzers do not dilute the sample and thus cannot directly control matrix resistivity by dilution in saline; instead, these analyzers derive an expected conductivity value by measuring the plasma cations. The measured conductivity is compared with the expected conductivity calculated from the measurement of cation concentrations, and the difference is calibrated to specimen hematocrit.
This calculation assumes that the bulk resistivity contributions from proteins, nonionized molecules, unmeasured cations, and their paired anions are either constant between individuals or linearly related to the cation activity measured in each specimen. The BGE instrument bases the calculation on sodium activity alone, whereas both sodium and potassium are used in Nova and i-STAT instruments.
Because direct resistivity methods rely on assumptions concerning the composition of whole blood, we anticipated that specimens from several important categories of patients likely to be served by such analyzers might yield erroneous hematocrit determinations. We therefore sought to determine the reliability of hematocrit measurements on one such instrument, the BGE analyzer, in specimens with abnormal amounts of electrolytes or plasma proteins by comparison with determinations from electronic cell counters and with packed cell volume (PCV) measurement determined by centrifugation.
Materials and Methods

Study subjects.
Patient correlation studies were performed with hepariized whole-blood specimens remaining after completion of routine or emergency blood gas analyses initiated by the clinical staff of the hospital. Some studies utilized fresh blood drawn by standard venipuncture techniques from healthy volunteers. Blood specimens were also drawn from male SpragueDawley rats (Harlan Co., Indianapolis, IN) fed ad libitum. All studies were conducted in accordance with protocols approved by the Human Studies Committee (or the Animal Care Committee for the rat studies) of Washington University.
Specimen preparation.
The effects of plasma solutes on hematocrit were systematically investigated with hepariized blood samples obtained from healthy volunteers. Concentrated stock solutions of the solute of interest (NaC1 1.0 moIIL, sorbitol 2.0 moIIL, glucose 1.0 molfL) were prepared in either water or isotonic saline (as appropriate to the experiment).
Pooled whole blood was divided into aliquots and small volumes of stock solution were added, with simultaneous addition of diluent to maintain a constant dilution of the blood of 1:20 or less. After the samples were mixed gently, hematocrit was measured by the methods described below, in randomized order. The concentration (Na, glucose) and osmatic effects of the additive were determined with the remaining aliquot of sample. Wholeblood K was also measured as a check for hemolysis.
Animal studies. Nonfasted animals were weighed and then surgically prepared under light ether anesthesia for study in the awake state by a modification of the technique described by Cotlove (9) . One catheter (PE 50) was placed in the right femoral artery for the collection of blood and another in the left femoral vein for infusion.
Pairs of rats were placed in Plexiglas holders and allowed to recover from the effects of anesthesia.
A baseline blood sample (0.6 mL) was obtained in a heparinized arterial blood sampling syringe, and infusion was begun at a constant rate of 1.3 mL/h per 100 g of body weight (syringe infusion pump 22; Harvard Apparatus, South Natick, MA). Experimental rats received sorbitol (3.0 mol/L) in isotonic saline; control rats received saline alone. Blood samples were collected hourly and analyzed without delay for hematocrit and plasma osmolality (centrifugation at ilOOg for 5 mm yielded suitable plasma). Each animal was weighed again at the end of the experiment.
Analytical methods. Hematocrit was estimated by three methods: the BGE analyzer; the S-Plus Jr analyzer (Coulter Diagnostics), an EPC that dilutes specimens 6250-fold with an isotonic solution of 68.4 mmolJL Na2SO4, 68 mmolIL NaCl, 11 mmolIL dimethylurea, and 0. 4 
Osmotic Effects on Hematocnt
Over an extended evaluation, we observed that specimens from a few patients gave large method-dependent differences in hematocrit, differences that were reproducible on repeat measurement. One such patient, a 13-year-old girl, had been in apparently good .
health until sent home from school at 1200 on the day of admission; subsequently found by her mother in cardiopulmonary arrest, she was resuscitated and admitted to the hospital at about 1700 with severe dehydration. She received epinephrine, intravenous fluids, colloids, and bicarbonate but did not recover spontaneous breathing;
she died on the next day. The cause of death identified at autopsy was a sellar germinoma. Three specimens collected during the course of the patient's hospitalization had sufficient volume for anal-
ysis by the three comparison methods. The EPC hematocrit determined on the admission specimen (21%) was markedly different from the BGE and PCV hematocrit results (13% and 16%, respectively).
The other specimens, collected 14 fresh whole blood obtained from normal volunteers. In this and subsequent studies we compared the hematoobserved in the patient presented above. A replicate crit values obtained with either the BGE or EPC experiment yielded similar results (data not shown). analyzers with the PCV hematocrit, regarded as the Increasing the osmolality of whole blood with sorbitol best assessment of the true hematocrit. Fig. 1 (top) decreased BGE and PCV hematocrit measurements in shows the effect of altering the osmolality by increasing a manner similar to sodium (Fig. 1, middle) : BGE, the plasma sodium concentration from 129 to 191 PCV, and EPC hematocrits decreased 4.9%, 6.3%, and mmoIIL. Throughout this range, BGE hematocrit re-0.02% per 100 mosmol/kg increase in osmolality, results were within 1% of the PCV hematocrit value for spectively. If both sorbitol and sodium are excluded that specimen, with both decreasing approximately from erythrocytes, osmotic shrinkage of erythrocytes linearly with increasing sodium concentration and might occur as water moves out of the cells to equalize plasma osmolality (5.5% and 5.7% decreases in hematthe osmotic pressure, which would decrease cell volocrit per 100 mosmol/kg increase in osmolality, respecume. Decreased cell volume due to osmotic water shift tively).
In contrast, the EPC hematocrit remained shrinkage would be appreciated in the BGE and PCV constant ( Fig. 1) : 0.02% decrease per 100 mosmollkg methods, because these measure erythrocyte volume in increase in osmolality.
At 393 mosmollkg (Na 191 undiluted whale blood. Diluting the sample with isommol/L), the magnitude of the difference between BGE tonic saline during EPC analysis, however, causes a and EPC results (-6%) was about the same as that rapid reentry of H2O, restoring prehyperosmotic cellu- lar volume before the cells' passage through the measurement orifices. To test this hypothesis, we added glucose in place of sorbitol to whole blood, as in the preceding experiment. Because glucose equilibrates from plasma into cells, it should induce no osmotic shift of H20 from erythrocytes.
As anticipated from this model, increasing concentrations of glucose did not generate a method-dependent discrepancy in hematocrit values: Hematocrit decreased by 0.03%, 0.2%, and -0.9% per 100 mosmol/kg increase in osmolality for the BGE, PCV, and EPC methods, respectively (Fig. 1,  bottom) .
To establish whether the in vitro effects of osmolality on hematocrit methods were generally relevant in patients undergoing rapid and large shifts in plasma osmolality (e.g., after administration of hyperosmotic agents), we used rats as an in vivo model. Pairs of rats were infused for 3 h with either isotonic saline (control) or 3.0 molfL sorbitol in isotonic saline (experimental).
Specimens for hematocrit
and osmolality were collected hourly during the infusion and for 2 h after the infusion was stopped. The plasma osmolality of the control rats (n = 3) infused with saline did not change during the infusion, being 298 ± 1 mosmol/kg at time 0 and 294 ± 3 mosmol/kg 3 h later. Hematocrit decreased 5% during the course of the experiment, and there were no significant differences in results obtained with the different methods at any time during the experiment (data not shown). After 3 h of infusion with 3.0 mol/L sorbitol, however, the plasma osmolality of the experimental rats (n = 3) increased significantly, from 299 ± 3 to 393 ± 34 mosmollkg (P = 0.035). This high osmolality was maintained throughout the remainder of the experiment.
During infusion with sorbitol, the PCV hematocrit of the experimental rats initially declined modestly and then slowly returned to near the zero time value at the end of the experimental period; the BGE hematocrit closely tracked the PCV result (Fig. 2) . In contrast, the EPC hematocrit increased more rapidly, deviating from the PCV hematocrit results after 2 h of infusion, and continued to increase throughout the experiment. EPC hematocrit values were statistically significantly different (P <0.05) from PCV hematocrit at 2, 3, and 4 h after the start of the infusion.
The decreases in PCV and BGE hematocrits during the infusion (0-3 h) were expected, a consequence of osmotic shrinkage of erythrocytes in contact with increasingly hypertonic plasma. Reequilibration with isotonic saline during EPC measurements reduced this effect. The subsequent return of both BGE and PCV hematocrit to near initial values was predicted, as the rats lost free water through hyperosmotic urine production and concentrated their cells within a reduced circulating blood volume. The magnitude of the discrepancy between EPC hematocrit values and PCV or BGE values in this experiment was similar to that observed in our hyperosmotic patient described above. We observed that EPC, BGE, and PCV hematocrit values were in agreement at the start of the surgical procedure, before the patients' blood was diluted with bypass solution [mean ± SD values (%): 33 ± 7, 33 ± 7, and 34 ± 7, respectively, n = 9]. After connection of the bypass apparatus, hematocrit values (%) decreased on all three analytical methods (19 ± 5, 16 ± 4, and 19 ± 5, respectively) the BGE results being significantly lower than the PCV results (P = 0.0001).
Time (h)
Because the plasma protein values were also dramatically reduced by dilution of circulating blood with Plasma-Lyte (mean decrease, 31 g/L), we sought to determine whether changes in plasma protein could artifactually alter the apparent hematocrit measured by the BGE direct conductivity method. We substituted Plasma-Lyte for various proportions of the plasma component of whole blood. The BGE hematocrit values decreased with increasing Plasma-Lyte content of the samples: 1.3% decrease in hematocrit per 10 gfL decrease in plasma protein (Fig. 3) . No changes in hematocrit were observed with the EPC or PCV hematocrit methods (0.1% and -0.08% changes per 10 g/L decrease in plasma protein, respectively); therefore, the Fig.3 . Variation in BGE, EPC, and PVC ("spun") hematocrit results when plasma protein concentration was varied by removing a portion of plasma and replacing it with a protein-free electrolyte solution (Plasma-Lyte).
The resulting plasma protein concentration was measured in centrifuged aliquots.
effect was specific to the BGE analytical method. Two replicate experiments yielded similar results and showed that the effect of decreasing protein was a set bias, the BGE-measured hematocrit decreasing by -1-1.3% per 10 g/L decrease in plasma protein, regardless of starting hematocrit (data not shown).
Protein molecules in plasma are poorly conducting particles that occupy a considerable volume fraction of the plasma and increase the viscosity of blood; consequently, decreases in plasma protein concentrations decrease resistivity (increase conductivity) of the blood by replacing a low-conductivity volume of protein with high-conductivity electrolyte solution and by lowering viscosity. The BGE therefore measures a higher wholeblood conductivity for erythrocytes suspended in Plasma-Lyte than in plasma and calculates a correspondingly lower hematocrit.
We investigated this effect by suspending 350 L of washed, packed erythrocytes in 700 pi of various solutions of polyethylene glycol (PEG) (average molecular mass kDa) in 4.5 g/L NaC1 or of dextran (15-20 kDa) in 8.0 g/L NaC1. Dextran and PEG were chosen to mimic the space-filling and viscosity properties of protein. BGE hematocrit measurements decreased systematically with PEG concentration (1.4% decrease per 10 g/L decrease in PEG), whereas EPC and PCV hematocrit measurements were unchanged (0.05% and 0.14% decreases per 10 g/L decrease in PEG, respectively) (Fig. 4) Measurement of hematocrit by centrifuging (PCV) tends to overestimate the true volume percent of erythrocytes because a small amount of plasma is trapped in the cellular layer, increasing the apparent cell volume; also, the contribution of leukocytes and platelets to the PCV is difficult to assess (and in practice is ignored) (12, 13) . Erythrocytes with abnormal shape may result in inaccurate PCV hematocrit determinations as well (13) . Nevertheless, PCV hematocrit estimates provide for the overwhelming number of patients an accurate assessment of hematocrit.
Another favorable aspect of PCV hematocrit determinations is that there are no dilution steps, and cells are not exposed to conditions differing from the patient's plasma. In patients who are acutely hyperosmotic with an impermeable solute, in vivo erythrocyte cell volume will rapidly and reversibly decrease due to free water movement out of the cells to balance intracellular and extracellular osmotic force (12, 14) . PCV hematocrit measurements preserve this effect, and reflect the true circulating erythrocyte cell volume present in those patients (12) . It is not clear, however, that the PCV hematocrit value offers a clinical advantage in these patients over hematocrit values determined by an EPC method, which bathes the erythrocytes in an isotonic solution and measures an "isotonic" hematocrit (15) . Acute hypertonicity does not alter erythrocyte hemoglobin content, an equally important index of hematological function that is usually codetermined with EPC hematocrit. Physiological changes in hematocrit, excluding patients suffering a large blood loss, are usually slow in comparison with the acute hyperosmotic effects that produce a PCV/ EPC discrepancy.
EPC hematocrit determinations, which are insensitive to acute hyperosmotic shifts, may provide a more useful index of the hematological status of the patient than do PCV hematocrit determinations, which fluctuate with acute changes in tonicity.
The present study shows that, in patients with hypernatremia or other osmotic derangement, the BGE (and probably also other analyzers that measure hematocrit by conductivity in undiluted whole blood) yields hematocrit determinations agreeing closely with the PCV hematocrit, which is sensitive to osmotic shift of cellular water. Because the BGE and similar instruments lend themselves to near-patient testing, and because acutely hyperosmotic patients may tend to be segregated to areas such as intensive-care units where near-patient testing is increasingly prevalent, in many instances medical staff may rely on hematocrit results to manage such patients without waiting for the results of hemoglobin determinations.
It is important that users understand the potential for abnormal low (or rapidly falling) hematocrit values, which reflect changes in erythrocyte water content rather than changes in the oxygen-carrying capacity of the patient's circulation.
The inaccuracy due to abnormal protein concentrations of direct-reading hematocrit methods is an important consideration in near-patient testing, because many soverely ifi patients have low concentrations of plasma proteins, including patients with glomerular nephropathy, hepatic synthetic failure, and cardiac insufficiency. The magnitude of the decrease in hematocrit measured with the BGE was --1.3% for each 10 g/L decrease in plasma protein. Because the change appeared to occur irrespective of the starting hematocritvalue (i.e., it was a set bias), patients with low hematocrits will have proportionately larger changes in hematocrit with changes in plasma protein concentrations. For patients such as those on cardiopulmonary bypass, where plasma dilution with a protein-free electrolyte is accompanied by substantial decreases in hematocrit,artifactually decreased hematocrit could prompt earlier (and potentially unneeded) intervention(transfusion). Accordingly, our laborator; has ceased to rely on direct-reading hematocrit methods for these patients.
In another report of a direct-reading method that yielded falsely decreased hematocrits when blood for transfusion was diluted with saline (11), the authors speculated that the error in hematocrit determination was due to decreased protein concentrationsin diluted blood.
The artifactualchanges in BGE hematocrit with abnormal concentrations of plasma protein appear to be due to the nonconducting, "space fiffing" property of proteins, which occupy a noticeable fraction (1-7%) of the plasma volume. The ability of PEG to mimic protein, with approximately the same magnitude effect on hematocrit, suggests that the ionic character of the plasma proteins is not an important factor. Ion mobility, and thus conductance, is inversely proportional to the viscosity of the conducting medium (16); increasing protein or PEG concentrations thus increase viscosity and decrease conductance.
Further experiments, beyond the scope of this study, would be necessary to determine the contribution of viscosity changes to the observed effect on BGE hematocrit.
